Last reviewed · How we verify

Standard-of-care corticosteroid injections

Rhode Island Hospital · Phase 3 active Small molecule

Standard-of-care corticosteroid injections is a corticosteroid Small molecule drug developed by Rhode Island Hospital. It is currently in Phase 3 development for Treatment of various inflammatory conditions, including rheumatoid arthritis, asthma, and multiple sclerosis.

Corticosteroids reduce inflammation by inhibiting the production of pro-inflammatory cytokines and mediators.

Corticosteroids reduce inflammation by inhibiting the production of pro-inflammatory cytokines and mediators. Used for Treatment of various inflammatory conditions, including rheumatoid arthritis, asthma, and multiple sclerosis.

At a glance

Generic nameStandard-of-care corticosteroid injections
SponsorRhode Island Hospital
Drug classcorticosteroid
TargetGlucocorticoid receptor
ModalitySmall molecule
Therapeutic areaImmunology
PhasePhase 3

Mechanism of action

They do this by binding to and activating glucocorticoid receptors, which then translocate to the nucleus and regulate the expression of genes involved in the inflammatory response. This results in a decrease in the production of pro-inflammatory cytokines and mediators, leading to reduced inflammation.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Standard-of-care corticosteroid injections

What is Standard-of-care corticosteroid injections?

Standard-of-care corticosteroid injections is a corticosteroid drug developed by Rhode Island Hospital, indicated for Treatment of various inflammatory conditions, including rheumatoid arthritis, asthma, and multiple sclerosis.

How does Standard-of-care corticosteroid injections work?

Corticosteroids reduce inflammation by inhibiting the production of pro-inflammatory cytokines and mediators.

What is Standard-of-care corticosteroid injections used for?

Standard-of-care corticosteroid injections is indicated for Treatment of various inflammatory conditions, including rheumatoid arthritis, asthma, and multiple sclerosis.

Who makes Standard-of-care corticosteroid injections?

Standard-of-care corticosteroid injections is developed by Rhode Island Hospital (see full Rhode Island Hospital pipeline at /company/rhode-island-hospital).

What drug class is Standard-of-care corticosteroid injections in?

Standard-of-care corticosteroid injections belongs to the corticosteroid class. See all corticosteroid drugs at /class/corticosteroid.

What development phase is Standard-of-care corticosteroid injections in?

Standard-of-care corticosteroid injections is in Phase 3.

What are the side effects of Standard-of-care corticosteroid injections?

Common side effects of Standard-of-care corticosteroid injections include Adrenal insufficiency, Osteoporosis, Glaucoma, Cataracts, Hypertension.

What does Standard-of-care corticosteroid injections target?

Standard-of-care corticosteroid injections targets Glucocorticoid receptor and is a corticosteroid.

Related